ATRION (Nasdaq: ATRI ) is expected to report Q4 earnings around Feb. 19. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ATRION's revenues will grow 18.3% and EPS will increase 21.1%.
The average estimate for revenue is $30.2 million. On the bottom line, the average EPS estimate is $3.21.
Last quarter, ATRION tallied revenue of $30.6 million. GAAP reported sales were 0.6% higher than the prior-year quarter's $30.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $3.59. GAAP EPS of $3.59 for Q3 were 7.8% higher than the prior-year quarter's $3.33 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 48.6%, 160 basis points worse than the prior-year quarter. Operating margin was 31.6%, 120 basis points worse than the prior-year quarter. Net margin was 23.7%, 150 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $120.8 million. The average EPS estimate is $12.48.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 253 members out of 262 rating the stock outperform, and nine members rating it underperform. Among 85 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 83 give ATRION a green thumbs-up, and two give it a red thumbs-down.
Is ATRION the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add ATRION to My Watchlist.